Significance of Circulating Tumor Cells Detected by the CellSearch System in Patients with Metastatic Breast Colorectal and Prostate Cancer

Overview

Journal J Oncol

Specialty Oncology

Date 2009 Dec 18

PMID 20016752

Citations 326

Authors

M Craig Miller

Gerald V Doyle

Leon W M M Terstappen

Affiliations

Soon will be listed here.

Abstract

The increasing number of treatment options for patients with metastatic carcinomas has created a concomitant need for new methods to monitor their use. Ideally, these modalities would be noninvasive, be independent of treatment, and provide quantitative real-time analysis of tumor activity in a variety of carcinomas. Assessment of circulating tumor cells (CTCs) shed into the blood during metastasis may satisfy this need. We developed the CellSearch System to enumerate CTC from 7.5 mL of venous blood. In this review we compare the outcomes from three prospective multicenter studies investigating the use of CTC to monitor patients undergoing treatment for metastatic breast (MBC), colorectal (MCRC), or prostate cancer (MPC) and review the CTC definition used in these studies. Evaluation of CTC at anytime during the course of disease allows assessment of patient prognosis and is predictive of overall survival.

Citing Articles

Liquid biopsy in gastric cancer: A snapshot of the current state of the art.

Gasparello J, Ceccon C, Angerilli V, Comunello T, Sabbadin M, DAlmeida Costa F J Liq Biopsy. 2025; 7:100288.

PMID: 40027230 PMC: 11863821. DOI: 10.1016/j.jlb.2025.100288.

Development of PowerMag System II for Isolation of Circulating Tumor Cells with Improved Purity.

Ho C, Tsai H, Wang J, Wang C, Chiou C, Cheng J Biomedicines. 2025; 13(2).

PMID: 40002844 PMC: 11852382. DOI: 10.3390/biomedicines13020431.

Longitudinal Circulating Tumor Cell Collection, Culture, and Characterization in Pancreatic Adenocarcinomas.

Xiao J, Mukherji R, Sidarous G, Suguru S, Noel M, Weinberg B Cancers (Basel). 2025; 17(3).

PMID: 39941724 PMC: 11815863. DOI: 10.3390/cancers17030355.

Phenotypic diversity of CTCs and tdEVs in liquid biopsies of tumour-draining veins is linked to poor prognosis in colorectal cancer.

Cieslik S, Zafra A, Driemel C, Sudarsanam M, Cieslik J, Flugen G J Exp Clin Cancer Res. 2025; 44(1):9.

PMID: 39773651 PMC: 11708080. DOI: 10.1186/s13046-024-03259-6.

Novel biomarkers for monitoring and management of hepatocellular carcinoma.

Solhi R, Pourhamzeh M, Zarrabi A, Hassan M, Mirzaei H, Vosough M Cancer Cell Int. 2024; 24(1):428.

PMID: 39719624 PMC: 11668010. DOI: 10.1186/s12935-024-03600-1.

References

Budd G, Cristofanilli M, Ellis M, Stopeck A, Borden E, Miller M . Circulating tumor cells versus imaging--predicting overall survival in metastatic breast cancer. Clin Cancer Res. 2006; 12(21):6403-9. DOI: 10.1158/1078-0432.CCR-05-1769. View

Hayes D, Smerage J . Is there a role for circulating tumor cells in the management of breast cancer?. Clin Cancer Res. 2008; 14(12):3646-50. DOI: 10.1158/1078-0432.CCR-07-4481. View

Nagrath S, Sequist L, Maheswaran S, Bell D, Irimia D, Ulkus L . Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature. 2007; 450(7173):1235-9. PMC: 3090667. DOI: 10.1038/nature06385. View

Riethdorf S, Fritsche H, Muller V, Rau T, Schindlbeck C, Rack B . Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system. Clin Cancer Res. 2007; 13(3):920-8. DOI: 10.1158/1078-0432.CCR-06-1695. View

Paterlini-Brechot P, Benali N . Circulating tumor cells (CTC) detection: clinical impact and future directions. Cancer Lett. 2007; 253(2):180-204. DOI: 10.1016/j.canlet.2006.12.014. View

Kahn H, Presta A, Yang L, Blondal J, Trudeau M, Lickley L . Enumeration of circulating tumor cells in the blood of breast cancer patients after filtration enrichment: correlation with disease stage. Breast Cancer Res Treat. 2004; 86(3):237-47. DOI: 10.1023/B:BREA.0000036897.92513.72. View

Cohen S, Punt C, Iannotti N, Saidman B, Sabbath K, Gabrail N . Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J Clin Oncol. 2008; 26(19):3213-21. DOI: 10.1200/JCO.2007.15.8923. View

Tibbe A, de Grooth B, Greve J, Dolan G, Rao C, Terstappen L . Magnetic field design for selecting and aligning immunomagnetic labeled cells. Cytometry. 2002; 47(3):163-72. DOI: 10.1002/cyto.10060. View

Krivacic R, Ladanyi A, Curry D, Hsieh H, Kuhn P, Bergsrud D . A rare-cell detector for cancer. Proc Natl Acad Sci U S A. 2004; 101(29):10501-4. PMC: 489966. DOI: 10.1073/pnas.0404036101. View

10.

Larson C, Moreno J, Pienta K, Gross S, Repollet M, OHara S . Apoptosis of circulating tumor cells in prostate cancer patients. Cytometry A. 2004; 62(1):46-53. DOI: 10.1002/cyto.a.20073. View

11.

Cristofanilli M, Budd G, Ellis M, Stopeck A, Matera J, Miller M . Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med. 2004; 351(8):781-91. DOI: 10.1056/NEJMoa040766. View

12.

de Bono J, Scher H, Montgomery R, Parker C, Miller M, Tissing H . Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clin Cancer Res. 2008; 14(19):6302-9. DOI: 10.1158/1078-0432.CCR-08-0872. View

13.

Tibbe A, Miller M, Terstappen L . Statistical considerations for enumeration of circulating tumor cells. Cytometry A. 2007; 71(3):154-62. DOI: 10.1002/cyto.a.20369. View

14.

Cohen S, Punt C, Iannotti N, Saidman B, Sabbath K, Gabrail N . Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer. Ann Oncol. 2009; 20(7):1223-9. DOI: 10.1093/annonc/mdn786. View

15.

Pantel K, Alix-Panabieres C, Riethdorf S . Cancer micrometastases. Nat Rev Clin Oncol. 2009; 6(6):339-51. DOI: 10.1038/nrclinonc.2009.44. View

16.

Allard W, Matera J, Miller M, Repollet M, Connelly M, Rao C . Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res. 2004; 10(20):6897-904. DOI: 10.1158/1078-0432.CCR-04-0378. View

17.

Fidler I . The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer. 2003; 3(6):453-8. DOI: 10.1038/nrc1098. View

18.

Panteleakou Z, Lembessis P, Sourla A, Pissimissis N, Polyzos A, Deliveliotis C . Detection of circulating tumor cells in prostate cancer patients: methodological pitfalls and clinical relevance. Mol Med. 2008; 15(3-4):101-14. PMC: 2600498. DOI: 10.2119/molmed.2008.00116. View

19.

Pantel K, Riethdorf S . Pathology: are circulating tumor cells predictive of overall survival?. Nat Rev Clin Oncol. 2009; 6(4):190-1. DOI: 10.1038/nrclinonc.2009.23. View

20.

Rao C, Chianese D, Doyle G, Miller M, Russell T, Sanders Jr R . Expression of epithelial cell adhesion molecule in carcinoma cells present in blood and primary and metastatic tumors. Int J Oncol. 2005; 27(1):49-57. View